Nicotine replacement therapy. What has been accomplished--can we do better?

Gender differences in the pharmacology of nicotine addiction.

Addiction biology·2016

Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers.

Clinical pharmacology and therapeutics·2014

Delayed bupropion cardiotoxicity associated with elevated serum concentrations of bupropion but not hydroxybupropion.

Clinical toxicology (Philadelphia, Pa.)·2013

Genetic and pharmacokinetic determinants of response to transdermal nicotine in white, black, and Asian nonsmokers.

Clinical pharmacology and therapeutics·2013

CYP2A6 genotype but not age determines cotinine half-life in infants and children.

Clinical pharmacology and therapeutics·2013

CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion.

Clinical pharmacology and therapeutics·2012

Small-Cell Lung Cancer: Biology, Translational Science and Clinical Innovation.

Drugs·2026

Lunsotogene Parvec: First Approval.

Drugs·2026

Acoziborole: First Approval.

Drugs·2026

DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives.

Drugs·2026

Emerging Strategies Targeting the PI3K/AKT/mTOR Pathway in HR+/HER2- Advanced Breast Cancer.

Drugs·2026

Balancing Act: The Dual Roles of BAFF in Systemic Lupus Erythematosus.

Drugs·2026

AUT00206, a novel and selective Kv3.1/3.2 channel modulator, restores cognitive dysfunction and negative symptoms in an animal model for schizophrenia symptomatology.

Journal of psychopharmacology (Oxford, England)·2026

Hypernatremia as the Initial Presentation of Osmotic Demyelination Syndrome: A Rare Case with Favorable Neurological Outcome.

Case reports in neurology·2026

Calycosin attenuates LPS-induced microglia inflammatory responses and microglia-mediated synaptic impairment via modulation of TLR4/MyD88/NF-κB signaling pathway.

Frontiers in pharmacology·2026

Structure of NHE6 and its lipid-mediated interactions regulating endosomal pH.

Nature communications·2026

Trigeminal Nerve Electrical Stimulation Attenuates Hypoxic-Ischemic Brain Injury by Regulating GLT-1-mediated Endoplasmic Reticulum Stress.

Brain research bulletin·2026

Divergent cortical-subcortical intrinsic neural timescales in first-episode drug-naïve or minimally treated schizophrenia.

Asian journal of psychiatry·2026

Related Experiment Videos

Nicotine replacement therapy. What has been accomplished--can we do better?

Related Concept Videos

Gender differences in the pharmacology of nicotine addiction.

Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers.

Delayed bupropion cardiotoxicity associated with elevated serum concentrations of bupropion but not hydroxybupropion.

Genetic and pharmacokinetic determinants of response to transdermal nicotine in white, black, and Asian nonsmokers.

CYP2A6 genotype but not age determines cotinine half-life in infants and children.

CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion.

Small-Cell Lung Cancer: Biology, Translational Science and Clinical Innovation.

Lunsotogene Parvec: First Approval.

Acoziborole: First Approval.

DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives.

Emerging Strategies Targeting the PI3K/AKT/mTOR Pathway in HR+/HER2- Advanced Breast Cancer.

Balancing Act: The Dual Roles of BAFF in Systemic Lupus Erythematosus.

AUT00206, a novel and selective Kv3.1/3.2 channel modulator, restores cognitive dysfunction and negative symptoms in an animal model for schizophrenia symptomatology.

Hypernatremia as the Initial Presentation of Osmotic Demyelination Syndrome: A Rare Case with Favorable Neurological Outcome.

Calycosin attenuates LPS-induced microglia inflammatory responses and microglia-mediated synaptic impairment via modulation of TLR4/MyD88/NF-κB signaling pathway.

Structure of NHE6 and its lipid-mediated interactions regulating endosomal pH.

Trigeminal Nerve Electrical Stimulation Attenuates Hypoxic-Ischemic Brain Injury by Regulating GLT-1-mediated Endoplasmic Reticulum Stress.

Divergent cortical-subcortical intrinsic neural timescales in first-episode drug-naïve or minimally treated schizophrenia.

Related Experiment Videos

Nicotine replacement therapy. What has been accomplished--can we do better?

Related Concept Videos

Related Articles